Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Achini Anuja Nandasena"'
Autor:
Chandima Jeewandara, Achala Kamaladasa, Pradeep Darshana Pushpakumara, Deshni Jayathilaka, Inoka Sepali Aberathna, Danasekara Rallage Saubhagya Rasikangani Danasekara, Dinuka Guruge, Thushali Ranasinghe, Shashika Dayarathna, Thilagaraj Pathmanathan, Gayasha Somathilake, Panambara Arachchige Deshan Madhusanka, Shyrar Tanussiya Ramu, Tibutius Thanesh Pramanayagam Jayadas, Heshan Kuruppu, Ayesha Wijesinghe, Herath Mudiyanselage Thashmi Nimasha, Dushantha Milroy, Achini Anuja Nandasena, Poththawela Kankanam Gamage Nilanka Sanjeewani, Ruwan Wijayamuni, Sudath Samaraweera, Lisa Schimanski, T. K. Tan, Tao Dong, Graham S. Ogg, Alain Townsend, Gathsaurie Neelika Malavige
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Here the authors show in a large cohort of healthcare workers that one dose of the AZD1222 vaccine seroconverts 92.9% of vaccinees, irrespective of age and gender, and results in high antibody titers to wild-type SARS-CoV-2 but only low titers to the
Externí odkaz:
https://doaj.org/article/8ce8a0ccd45c48f3a81d8d158056219c
Autor:
Tibutius T. P. Jayadas, Ruwan Wijayamuni, Pradeep Darshana Pushpakumara, Thushali Ranasinghe, Ayesha Wijesinghe, Dinuka Guruge, Alain Townsend, Achini Anuja Nandasena, Poththawela Kankanam Gamage Nilanka Sanjeewani, Shashika Dayarathna, Heshan Kuruppu, Gayasha Somathilake, Sudath Samaraweera, Herath Mudiyanselage Thashmi Nimasha, Chandima Jeewandara, Danasekara Rallage Saubhagya Rasikangani Danasekara, Panambara Arachchige Deshan Madhusanka, Shyrar Tanussiya Ramu, Dushantha Milroy, Inoka Sepali Aberathna, Gathsaurie Neelika Malavige, Graham S. Ogg, Lisa Schimanski, Deshni Jayathilaka, Achala Kamaladasa, Thilagaraj Pathmanathan, Tiong Kit Tan, Tao Dong
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications
Nature Communications
Several COVID-19 vaccines have received emergency approval. Here we assess the immunogenicity of a single dose of the AZD1222 vaccine, at one month, in a cohort of health care workers (HCWs) (629 naïve and 26 previously infected). 93.4% of naïve HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8116d146cae1a06637e6942a3a0178ac
https://doi.org/10.1038/s41467-021-24579-7
https://doi.org/10.1038/s41467-021-24579-7
Autor:
Thushali Ranasinghe, Shyrar Tanussiya, Tiong Kit Tan, Deshni Jayathilaka, Saubhagyagya Danasekara, Tao Dong, Dushantha Milroy, Pradeep Pushpakumara, Nimasha Thashmi, Lisa Schimanski, Ruwan Wijayamuni, Thilagaraj T Padmanadan, Sudath Samaraweera, Alain Townsend, Heshan Kuruppu, Achala Kamaladasa, Achini Anuja Nandasena, Tibutius T. P. Jayadas, Gayasha Somathilaka, Gathsaurie Neelika Malavige, Shashika Dayaratne, Deshan Madusanka, Dinuka Guruge, Graham S. Ogg, Chandima Jeewandara, Ayesha Wijesinghe, Nilanka Sanjeewani, Inoka Sepali
BackgroundIn order to determine the immunogenicity of a single dose of the AZD1222/Covishield vaccine in a real-world situation, we assessed the immunogenicity, in a large cohort of health care workers in Sri Lanka.MethodsSARS-CoV-2 antibodies was ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7ffa260114b33d7a1698ce3891ab18d
https://doi.org/10.1101/2021.04.09.21255194
https://doi.org/10.1101/2021.04.09.21255194
